Literature DB >> 6287475

beta-Endorphin enhances lymphocyte proliferative responses.

S C Gilman, J M Schwartz, R J Milner, F E Bloom, J D Feldman.   

Abstract

The opioid peptides alpha- and beta-endorphin and [D-Ala2, Met5]enkephalin were investigated for their effect on the proliferation of resting and activated rat splenic lymphocytes in vitro. beta-Endorphin enhanced the proliferative response of spleen cells to the T cell mitogens concanavalin A and phytohemagglutinin. The effect of beta-endorphin was dose dependent and occurred at peptide concentrations similar to those found in rat plasma. alpha-Endorphin and [D-Ala2, Met5]enkephalin did not affect the proliferative responses to any mitogen tested. Furthermore, the potentiating effect of beta-endorphin was not reversed by treatment with 10 microM naloxone. None of the peptides had any effect on resting, unstimulated spleen cells or on the response to a mixture of lipopolysaccharide and dextran sulfate, which is specifically mitogenic for B lymphocytes. The pharmacological properties of the beta-endorphin potentiation indicate that the effect may be mediated by a nonopiate but beta-endorphin-specific mechanism. These results suggest a possible role for peripheral beta-endorphin and may provide a link between stress and disease susceptibility.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287475      PMCID: PMC346611          DOI: 10.1073/pnas.79.13.4226

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Influence of brain and behavior on the immune system.

Authors:  M Stein; R C Schiavi; M Camerino
Journal:  Science       Date:  1976-02-06       Impact factor: 47.728

2.  Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity.

Authors:  N Ling; R Burgus; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

3.  Foot-shock induced stress increases beta-endorphin levels in blood but not brain.

Authors:  J Rossier; E D French; C Rivier; N Ling; R Guillemin; F E Bloom
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

4.  The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.

Authors:  P E Gilbert; W R Martin
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

5.  Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro.

Authors:  R H Gisler; L Schenkel-Hulliger
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

6.  Hormonal regulation of the immune response. I. Induction of an immune response in vitro with lymphoid cells from mice exposed to acute systemic stress.

Authors:  R H Gisler; A E Bussard; J C Mazié; R Hess
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

7.  Stimulation of DNA synthesis by tumour promoter and pure mitogenic factors.

Authors:  P Dicker; E Rozengurt
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.

Authors:  I Lemaire; R Tseng; S Lemaire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.

Authors:  N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  44 in total

1.  Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors.

Authors:  Ali G Karaji; David Reiss; Audrey Matifas; Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-22       Impact factor: 4.147

2.  β-endorphin binding in cultured adrenal cortical cells.

Authors:  R A Gelfand; A Bobrow; L Pham; C Young; L Parker
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

Review 3.  Hormones and the immune response.

Authors:  A K Bhalla
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

4.  Two opposing modes of action of beta-endorphin on lymphocyte function.

Authors:  P van den Bergh; J Rozing; L Nagelkerken
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

5.  Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro.

Authors:  R P Saneto; A Altman; R L Knobler; H M Johnson; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  "Anatomy of an Illness": control from a caregiver's perspective.

Authors:  Mark L Laudenslager
Journal:  Brain Behav Immun       Date:  2013-09-06       Impact factor: 7.217

Review 7.  Retinoids and the control of growth/death decisions in human neuroblastoma cell lines.

Authors:  G Melino; C J Thiele; R A Knight; M Piacentini
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

8.  Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease.

Authors:  H Yamamoto; K Morise; K Kusugami; A Furusawa; T Konagaya; Y Nishio; H Kaneko; K Uchida; H Nagai; T Mitsuma; H Nagura
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

9.  Dual signal transduction through delta opioid receptors in a transfected human T-cell line.

Authors:  B M Sharp; N A Shahabi; W Heagy; K McAllen; M Bell; C Huntoon; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

10.  Regulation of interleukin-1beta and interleukin-8 production by agonists of mu and delta opiate receptors in vitro.

Authors:  S V Gein; K G Gorshkova; S P Tendryakova
Journal:  Neurosci Behav Physiol       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.